Hwail Pharmaceutical Co.,Ltd. (KOSDAQ:061250)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,071.00
+1.00 (0.09%)
At close: Feb 13, 2026

Hwail Pharmaceutical Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Feb '26 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
91,031109,67187,49378,70380,50297,411
Market Cap Growth
-13.53%25.35%11.17%-2.23%-17.36%168.23%
Enterprise Value
-115,940109,33187,46495,297107,903
Last Close Price
1071.002504.641961.201723.271696.572075.90
PE Ratio
22.5717.1816.0519.0519.1219.25
PS Ratio
0.840.980.820.820.861.06
PB Ratio
0.931.100.880.880.931.19
P/TBV Ratio
0.971.150.930.930.981.19
P/FCF Ratio
8.4411.96----
P/OCF Ratio
8.1311.45--11.5596.95
EV/Sales Ratio
-1.041.030.911.011.18
EV/EBITDA Ratio
-22.3323.1513.3813.6411.96
EV/EBIT Ratio
-52.0656.0218.7517.1214.14
EV/FCF Ratio
-12.65----
Debt / Equity Ratio
0.160.150.270.240.250.22
Debt / EBITDA Ratio
3.042.915.683.313.111.97
Debt / FCF Ratio
1.471.65----
Net Debt / Equity Ratio
0.040.050.200.140.130.10
Net Debt / EBITDA Ratio
0.770.974.271.901.650.91
Net Debt / FCF Ratio
0.370.55-2.53-2.97-5.20-1.23
Asset Turnover
0.800.830.810.780.800.87
Inventory Turnover
3.463.423.343.113.063.27
Quick Ratio
2.552.661.462.171.671.96
Current Ratio
3.683.972.423.392.863.12
Return on Equity (ROE)
1.94%6.42%5.80%4.71%5.00%6.67%
Return on Assets (ROA)
1.05%1.03%0.93%2.37%2.95%4.50%
Return on Invested Capital (ROIC)
1.74%1.55%1.32%4.39%4.70%6.39%
Return on Capital Employed (ROCE)
2.10%2.00%1.80%4.60%5.70%8.60%
Earnings Yield
2.11%5.82%6.23%5.25%5.23%5.20%
FCF Yield
11.85%8.36%-9.10%-5.33%-2.75%-6.89%
Payout Ratio
105.38%31.79%24.80%32.73%31.20%20.39%
Buyback Yield / Dilution
-0.15%0.06%-0.21%0.24%-1.65%-0.03%
Total Shareholder Return
-0.15%0.06%-0.21%0.24%-1.65%-0.03%
Updated May 15, 2017. Source: S&P Global Market Intelligence. Standard template. Financial Sources.